These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23872714)

  • 1. Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects.
    Banerjee N; Paul S; Sau TJ; Das JK; Bandyopadhyay A; Banerjee S; Giri AK
    Toxicol Sci; 2013 Oct; 135(2):300-8. PubMed ID: 23872714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy.
    Chanda S; Dasgupta UB; Guhamazumder D; Gupta M; Chaudhuri U; Lahiri S; Das S; Ghosh N; Chatterjee D
    Toxicol Sci; 2006 Feb; 89(2):431-7. PubMed ID: 16251483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the TNF-α and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects.
    Banerjee N; Nandy S; Kearns JK; Bandyopadhyay AK; Das JK; Majumder P; Basu S; Banerjee S; Sau TJ; States JC; Giri AK
    Toxicol Sci; 2011 May; 121(1):132-9. PubMed ID: 21357384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased microRNA 21 expression contributes to arsenic induced skin lesions, skin cancers and respiratory distress in chronically exposed individuals.
    Banerjee N; Bandyopadhyay AK; Dutta S; Das JK; Roy Chowdhury T; Bandyopadhyay A; Giri AK
    Toxicology; 2017 Mar; 378():10-16. PubMed ID: 28069514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice.
    Suzuki T; Nohara K
    J Appl Toxicol; 2013 Sep; 33(9):951-8. PubMed ID: 22733434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects.
    Bhattacharjee P; Das N; Chatterjee D; Banerjee A; Das JK; Basu S; Banerjee S; Majumder P; Goswami P; Giri AK
    Mutat Res; 2013 Jul; 755(1):1-5. PubMed ID: 23644288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India.
    Ghosh P; Banerjee M; De Chaudhuri S; Chowdhury R; Das JK; Mukherjee A; Sarkar AK; Mondal L; Baidya K; Sau TJ; Banerjee A; Basu A; Chaudhuri K; Ray K; Giri AK
    J Expo Sci Environ Epidemiol; 2007 May; 17(3):215-23. PubMed ID: 16835595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions.
    Millares L; Rosell A; Setó L; Sanz J; Andreo F; Monsó E
    Oncol Rep; 2014 Oct; 32(4):1435-40. PubMed ID: 25069886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India.
    De Chaudhuri S; Mahata J; Das JK; Mukherjee A; Ghosh P; Sau TJ; Mondal L; Basu S; Giri AK; Roychoudhury S
    Mutat Res; 2006 Oct; 601(1-2):102-12. PubMed ID: 16930632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic exposure through drinking water leads to senescence and alteration of telomere length in humans: A case-control study in West Bengal, India.
    Chatterjee D; Bhattacharjee P; Sau TJ; Das JK; Sarma N; Bandyopadhyay AK; Roy SS; Giri AK
    Mol Carcinog; 2015 Sep; 54(9):800-9. PubMed ID: 24665044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
    Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
    Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alteration of mitochondrial biogenesis regulatory genes in arsenic exposed individuals (with and without skin lesions) and in skin cancer tissues: A case control study.
    Sanyal T; Paul M; Bhattacharjee S; Bhattacharjee P
    Chemosphere; 2020 Nov; 258():127305. PubMed ID: 32563914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
    Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
    Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications.
    Geraldes C; Gonçalves AC; Cortesão E; Pereira MI; Roque A; Paiva A; Ribeiro L; Nascimento-Costa JM; Sarmento-Ribeiro AB
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):713-720.e2. PubMed ID: 27622827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
    Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.